Effect of Tirzepatide on Markers of MASLD in Patients With Obesity (NCT06934642)
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity: A Pilot Study
🩺 Plain-English Summary (8th-Grade Level)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is the most common cause of chronic liver disease worldwide and predominately affects individuals with overweight and obesity, as well as those with type 2 diabetes and cardiovascular disease. Tirzepatide is a medication used to treat type 2 diabetes and obesity. It has also been shown to help with MASLD. The purpose of this study is to study how tirzepatide affects the liver in patients with MASLD. Participants will be asked to: * Take tirzepatide for 12 months. * Come in for clinic visits every 3 months. * Have blood drawn at baseline, 6, and 12 months. * Complete a liver ultrasound at baseline and at 12 months.
Who can join: Review the eligibility criteria below.
Location: University of New Mexico Health Sciences Center — Albuquerque, New Mexico
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of New Mexico Health Sciences Center — Albuquerque, New Mexico
📞 Contact the Study Coordinator
Phone: (505) 272-3840
Email: KrGonzales@salud.unm.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in MASLD
- Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis — Birmingham, Alabama
- Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease — Detroit, Michigan
- Accurate Point of Care Liver Disease Diagnostics (Phase 2) — La Jolla, California
- Quantitative Ultrasound to Assess Steatotic Liver Disease in Children — La Jolla, California
- A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease — Nashville, Tennessee
- Endoscopic Ultrasound Shear Wave Elastography Study — Boston, Massachusetts
Explore by condition: All MASLD clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.